FDA Advisory Committee Unanimously Recommends Approval of Merck’s VYTORIN® (ezetimibe/simvastatin) for Use in Patients …

Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the Endocrinologic …

Published by jingxin